Register information Patent

DE file number : 60 2013 081 433.3 (Status: pending/in force, Query started: April 27, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2013 081 433.3
96EP file numberEAKZ19 18 5175.7
97EP publication numberEPN3575326
54Designation/titleTIBEHANDLUNG VON CD47+-KRANKHEITSZELLEN MIT SIRP-ALPHA-FC-FUSIONEN
51IPC main classICM
(ICMV)
C07K 19/00 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 38/16 (2006.01), A61K 38/45 (2006.01), A61P 35/02 (2006.01), C07K 14/705 (2006.01), C07K 16/00 (2006.01), C12N 15/62 (2006.01), A61K 38/00 (2006.01)
22DE application dateDATDec 17, 2013
96EP application dateEATDec 17, 2013
43Date of first publicationOTDec 4, 2019
Date of publication of grantPETApr 13, 2022
71/73Applicant/ownerINHPfizer Inc., New York, NY, US
72InventorINUGER, Robert Adam, Richmond Hill, Ontario L4C 7S4, CA; SLAVOVA-PETROVA, Penka Slavtcheva, Toronto, Ontario M8V 3X1, CA; PANG, Xinli, Brampton, Ontario L6R 3H1, CA
74RepresentativeVTRKraus & Lederer PartGmbB, 80539 München, DE
Address for service Kraus & Lederer PartGmbB, 80539 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201261738008 P
Dec 17, 2012
Due dateFT
FG
Dec 31, 2025
Annual fee for the 13th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003575326A1
Searchable text: EP000003575326A1
Original document: EP000003575326B1
Searchable text: EP000003575326B1
43Date of first publicationEVTDec 4, 2019
Date of the first transfer into DPMAregisterEREGTDec 4, 2019
Date of the (most recent) update in DPMAregisterREGTNov 16, 2024
(Show all update days)(Hide all update days)
  • Nov 16, 2024
    • Due date: changed
  • Jul 24, 2024
    • St.36: changed (technical change)
  • May 2, 2024; Jan 2, 2024; Dec 22, 2023; Nov 15, 2023; Apr 6, 2023; Mar 21, 2023; Mar 2, 2023; Jul 14, 2022; Jun 10, 2022; Jun 9, 2022; Apr 6, 2022; Apr 2, 2022; Mar 24, 2022
    • Historical data not available for this/these date(s)
  • Dec 4, 2019
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Dec 4, 2019  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Jan 16, 2020 Jan 16, 2020 Details anzeigen
3 New applicant/owner details New applicant/owner details Apr 5, 2022 Jul 14, 2022 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Apr 13, 2022  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Apr 28, 2022 Apr 28, 2022 Details anzeigen
6 New applicant/owner details New applicant/owner details Jun 8, 2022 Jul 14, 2022 Details anzeigen
7 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Jan 16, 2023 Apr 6, 2023 Details anzeigen
8 New applicant/owner details New applicant/owner details Mar 20, 2023 Apr 27, 2023 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTDec 4, 2019
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTJan 16, 2020
Issue numberHN3
YearPJ2020
Publication dateVTJan 16, 2020
Type of publicationPARTBibliographic data
View procedures New applicant/owner details (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTApr 5, 2022
Issue numberHN28
YearPJ2022
Publication dateVTJul 14, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHTrillium Therapeutics ULC, Mississauga, Ontario, CA
71/73Previous applicant/ownerINHFTrillium Therapeutics Inc., Mississauga, Ontario, CA
Date of update of the procedureREGTJul 14, 2022
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTApr 13, 2022
Date of update of the procedureREGTMar 24, 2022
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTApr 28, 2022
Issue numberHN17
YearPJ2022
Publication dateVTApr 28, 2022
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTApr 2, 2022
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJun 8, 2022
Issue numberHN28
YearPJ2022
Publication dateVTJul 14, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHPF Argentum IP Holdings LLC, New York, NY, US
71/73Previous applicant/ownerINHFTrillium Therapeutics ULC, Mississauga, Ontario, CA
Date of update of the procedureREGTJul 14, 2022
View procedures Procedure relating to EP application (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTJan 16, 2023
Issue numberHN14
YearPJ2023
Publication dateVTApr 6, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTMar 21, 2023
View procedures New applicant/owner details (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTMar 20, 2023
Issue numberHN17
YearPJ2023
Publication dateVTApr 27, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHPfizer Inc., New York, NY, US
71/73Previous applicant/ownerINHFPF Argentum IP Holdings LLC, New York, NY, US
Date of update of the procedureREGTApr 6, 2023